ICON

$272.81 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About ICON

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.

Stock Analysis

last close $272.81
1-mo return -1%
3-mo return 4%
avg daily vol. 404.18T
52-week high 301.72
52-week low 168.76
market cap. $22.1B
forward pe 24.6
annual div. -
roe 3.6%
ltg forecast 25.5%
dividend yield -
annual rev. $3.7B
inst own. 96.4%
baraka

Subscribe now for daily local and international financial news

Subscribe